MedTrace Logo

FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test

NCT02018198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 540

Last updated 2022-11-17

No results posted yet for this study

Summary

The aim of this study is to determine performance characteristics of the FebriDx test in predicting viral or bacterial infection etiology among febrile (observed or reported) patients presenting the emergency department, urgent care centers or primary care offices with suspected acute respiratory tract infection.

Conditions

  • Acute Respiratory Tract Infections

Interventions

DIAGNOSTIC_TEST

FebriDx

Point of Care Host Immune Response Test

Sponsors & Collaborators

  • Rapid Pathogen Screening

    lead INDUSTRY

Principal Investigators

  • Nathan Shapiro, MD · Beth Israel Deaconess Medical Center

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2021-04-30
Completion
2021-06-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02018198 on ClinicalTrials.gov